This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Ulrich Koenig: Innovator in Cancer Immunotherapy
Introduction
Ulrich Koenig is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of cancer immunotherapy through his innovative research and patents. His work focuses on tumor-associated antigens and their potential applications in treating various cancers.
Latest Patents
Ulrich Koenig holds a patent for a tumor-associated antigen known as R11. This patent encompasses tumor-associated antigens, immunogenic peptides derived from them, and DNA molecules coding for these antigens. The use of these innovations in the immunotherapy of cancers represents a significant advancement in cancer treatment.
Career Highlights
Koenig is affiliated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research in immunotherapy.
Collaborations
Some of his notable coworkers include Thomas Woelfel and Renate Konopitzky. Their collective expertise enhances the research environment and fosters innovation in cancer treatment.
Conclusion
Ulrich Koenig's contributions to cancer immunotherapy through his patent and work at Boehringer Ingelheim International GmbH highlight his role as a key innovator in the field. His research continues to pave the way for new therapeutic approaches to combat cancer.